GestVision

Curated by Signal

Point of care diagnostic test for preeclampsia

Overview

GestVision develops tests for detection of preeclampsia in pregnant women. They have developed a urine test to detect preeclampsia which is characterised by high blood pressure and urine protein. They use a Congo Red dye that can detect protein abnormalities in a urine of patients with preeclampsia, though not in urine from patients with a normal pregnancy

Key facts

Founded: 2014
Headquarters: Guilford, United States
Stage: Sign up to view
Industry: Life Sciences Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Cauchy Analytics
Developer of non-invasive cardiac imaging and monitoring devices
Life Sciences TechnologySomerville, United States
HeartIT
Medical image viewing, management and sharing platforms
Life Sciences TechnologyDurham, United States
Aikium
Developer of protein therapeutics for neuro-inflammation and oncology
Life Sciences TechnologyBerkeley, United States

About GestVision

What does GestVision do?

GestVision develops tests for detection of preeclampsia in pregnant women.

Where is GestVision headquartered?

GestVision is headquartered in Guilford, United States.

When was GestVision founded?

GestVision was founded in 2014.

Which sector is GestVision in?

GestVision operates in Life Sciences Technology.

Who are GestVision's competitors?

Companies similar to GestVision include Cauchy Analytics, HeartIT, and Aikium.